SafeTest


Developer and manufacturer of lateral-flow rapid diagnostic tests for human and animal health. Offers end-to-end services including antigen/antibody conjugation with colloidal gold, membrane impregnation and assembly of lateral-flow devices, nanoparticle production, prototype validation and scale-up to kit manufacturing. Provides training, consultancy and technical support; holds ANVISA Good Manufacturing Practices (BPF) certification for in vitro diagnostics.

Industries

biotechnology
health-care
health-diagnostics

Nr. of Employees

small (1-50)

SafeTest

Av. José Cândido da Silveira, 2100, Salas 5, 6 e 7 – Horto Florestal – Belo Horizonte CEP: 31035-536


Products

Rapid diagnostic test kits (lateral-flow)

Rapid lateral-flow diagnostic kits for detection of diseases in human and animal health, developed and produced domestically.


Services

End-to-end development of rapid lateral-flow diagnostic prototypes from provided antigen/antibody material through to validated prototypes.

Production of gold nanoparticles (~40 nm) and conjugation of proteins/peptides/antibodies for use in immunochromatographic assays.

Validation and scale-up of prototypes to large-scale production of rapid-test kits, including assembly and QC processes.

Theoretical and practical courses, consultancy and hands-on training for individuals, teams and companies on rapid-test development, conjugation and production processes.

Technical assistance for product application, demonstrations and troubleshooting related to diagnostic products and processes.

Expertise Areas

  • Rapid diagnostic test development
  • Lateral-flow immunoassays
  • Nanoparticle synthesis for diagnostics
  • Scale-up and manufacturing of IVD kits
  • Show More (2)

Key Technologies

  • Lateral-flow immunoassay
  • Colloidal gold nanoparticle synthesis (~40 nm)
  • Nitrocellulose membrane impregnation
  • Immunochromatography
  • Show More (2)

News & Updates

Announcement of a domestically developed rapid COVID-19 test.

Coverage in Forbes about a rapid COVID-19 test with a 15-minute turnaround and low cost.

Recognized as the winner of the 3rd edition of Biostartup Lab, a pre-acceleration program focused on life sciences.

Selected as one of 40 startups for the 4th round of the SEED acceleration program.

Company leadership was selected for the Biotech II program supporting biotechnology development and public-private matchmaking in the Mercosur.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.